CombiGene´s lead project CG01 has received funding from the European Union´s Horizon 2020 research and innovation programme

CombiGene announces a public offer to the holders of shares and warrants of series TO1 in Panion Animal Health

Apr 18, 2019

CombiGene discloses the information provided herein pursuant to the Takeover Rules and the EU:s Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, on 18 April 2019 at 08.30 a.m. CET.

Jan Nilsson (CEO)
Arne Ferstad (Chairman of the board)